Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.1391992251965767e-43,34.19080573405833,3380.815366189201,"['RPL30', 'RPL32', 'RPL10', 'RPL34', 'RPLP1', 'RPL12', 'RPL11', 'RPL36A', 'RPL10A', 'RPL9', 'RPS4X', 'RPS15', 'RPS14', 'RPS15A', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS2', 'RPS27A', 'RPL18', 'RPL39', 'RPS10', 'RPL17', 'RPS13', 'RPS12', 'RPL41', 'RPL21', 'RPS8', 'RPS5', 'RPL22', 'RPL35A', 'RPS3A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL37A', 'RPL24', 'RPL26', 'FAU', 'RPL29', 'RPS21', 'RPS24']",1.5265269617634127e-41,0,0,48
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.114086625770574e-32,28.569745649263723,2083.7086893582127,"['COX7B', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'COX8A', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO']",1.4164380392662846e-30,0,0,37
3,Nonalcoholic fatty liver disease WP4396,2.3104852673500235e-20,13.74920280612245,621.6598143995253,"['NDUFA13', 'COX7B', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS']",1.032016752749677e-18,0,0,30
4,Oxidative phosphorylation WP623,8.513081536803923e-12,14.25679012345679,363.39727040813386,"['ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB2', 'NDUFB1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MG', 'ATP5MF']",2.851882314829314e-10,0,0,16
5,Mitochondrial CIV Assembly WP4922,1.3102848012965466e-11,22.96031746031746,575.3440319082353,"['COX8A', 'COX7B', 'PET100', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",3.511563267474745e-10,0,0,13
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.5937737943613992e-09,13.099773242630386,265.3642179625417,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFS6', 'NDUFS5']",3.559428140740458e-08,0,0,13
7,Mitochondrial complex III assembly WP4921,3.876693781503136e-06,24.827142857142857,309.3593058951124,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",7.421099524591717e-05,0,0,6
8,Pyrimidine metabolism WP4022,0.000743837535455289,4.738335046248715,34.13348690182821,"['POLD4', 'POLR3GL', 'POLE3', 'NME2', 'POLR2I', 'POLR2J', 'POLR2K', 'POLR2L']",0.01245927871887609,0,0,8
9,Proteasome Degradation WP183,0.0019451022320047444,5.380434782608695,33.58704529582877,"['PSMA5', 'PSMB6', 'PSMD7', 'H2AFZ', 'HLA-B', 'PSMB10']",0.028960411009848416,0,0,6
10,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.002202399599982806,inf,inf,"['ELOB', 'ELOC']",0.0295121546397696,0,0,2
11,Dual hijack model of Vif in HIV infection WP3300,0.012406122113962137,20.408450704225352,89.58422518784477,"['ELOB', 'ELOC']",0.15112912393372058,0,0,2
12,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.020038262976457326,13.603286384976526,53.19036903937033,"['COX8A', 'COX5A']",0.21333200426092463,0,0,2
13,Copper homeostasis WP3286,0.020696388473074777,6.135689045936396,23.792950831230666,"['SP1', 'COX17', 'ATOX1']",0.21333200426092463,0,0,3
14,Cellular Proteostasis WP4918,0.029132748596486086,10.200704225352112,36.06859209877955,"['PFDN4', 'PFDN5']",0.2788420222806525,0,0,2
15,Type 2 papillary renal cell carcinoma WP4241,0.036531253544209136,4.717314487632509,15.61236328478378,"['CTSK', 'ELOB', 'ELOC']",0.32634586499493495,0,0,3
16,Eukaryotic Transcription Initiation WP405,0.04285948710316582,4.379606259464917,13.795007545355682,"['POLR2I', 'POLR2J', 'POLR2K']",0.3589482044890137,0,0,3
17,let-7 inhibition of ES cell reprogramming WP3299,0.047008337471375276,inf,inf,['EGR1'],0.370536307127311,0,0,1
18,Cytosolic DNA-sensing pathway WP4655,0.05703021941113791,3.8308303886925796,10.972164746093364,"['POLR3GL', 'POLR2K', 'POLR2L']",0.42455830006069334,0,0,3
19,Selenium Micronutrient Network WP15,0.06110894955693975,2.922998986828774,8.170065551780235,"['PRDX5', 'SELENOW', 'TXN', 'SELENOH']",0.430978907401575,0,0,4
20,DNA Mismatch Repair WP531,0.09154634076133135,4.529733959311424,10.830186123260885,"['POLD4', 'POLE3']",0.5858631046449281,0,0,2
21,MED and Pseudoachondroplasia genes WP4789,0.09181436714584694,20.340350877192982,48.57248307106079,['COL9A3'],0.5858631046449281,0,0,1
22,Composition of Lipid Particles WP3601,0.1345208283419696,10.16842105263158,20.398221077892657,['LPL'],0.8014044687183777,0,0,1
23,Base Excision Repair WP4752,0.1548404977903999,3.1338028169014085,5.845669602758452,"['POLD4', 'POLE3']",0.8014044687183777,0,0,2
24,Nucleotide Excision Repair WP4753,0.17174182566011398,2.909456740442656,5.125773070801653,"['POLD4', 'POLE3']",0.8014044687183777,0,0,2
25,Mitochondrial Gene Expression WP391,0.175225761788229,6.777777777777778,11.804720468474779,['SP1'],0.8014044687183777,0,0,1
26,Estrogen Receptor Pathway WP2881,0.175225761788229,6.777777777777778,11.804720468474779,['SP1'],0.8014044687183777,0,0,1
27,Homologous recombination WP186,0.175225761788229,6.777777777777778,11.804720468474779,['POLD4'],0.8014044687183777,0,0,1
28,Ciliary landscape WP4352,0.19438481719263895,1.5921150278293135,2.6077498673233634,"['IFT22', 'PSMD7', 'NDUFA5', 'MFAP1', 'MYL6B', 'COX6C']",0.8014044687183777,0,0,6
29,Androgen receptor signaling pathway WP138,0.20092993018425084,2.0381625441696114,3.2708412896589945,"['SUMO1', 'SP1', 'BAG1']",0.8014044687183777,0,0,3
30,AGE/RAGE pathway WP2324,0.20632979806000737,2.544894366197183,4.01655442691503,"['SP1', 'CYCS']",0.8014044687183777,0,0,2
31,Modulators of TCR signaling and T cell activation WP5072,0.20632979806000737,2.544894366197183,4.01655442691503,"['NDUFB10', 'ELOB']",0.8014044687183777,0,0,2
32,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.21402265528394482,5.082456140350877,7.8354874573091395,['LPL'],0.8014044687183777,0,0,1
33,MTHFR deficiency WP4288,0.21402265528394482,5.082456140350877,7.8354874573091395,['CYCS'],0.8014044687183777,0,0,1
34,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.21402265528394482,5.082456140350877,7.8354874573091395,['SP1'],0.8014044687183777,0,0,1
35,Alzheimer's disease WP2059,0.2257831371008929,1.9101148409893993,2.8425952976169673,"['ATP5MD', 'LPL', 'CYCS']",0.8014044687183777,0,0,3
36,Complement system WP2806,0.24156675572658995,2.2613458528951487,3.212489226965298,"['RPS19', 'TXN']",0.8014044687183777,0,0,2
37,Triacylglyceride synthesis WP325,0.25100064701555647,4.065263157894737,5.6194122960417685,['LPL'],0.8014044687183777,0,0,1
38,Constitutive Androstane Receptor Pathway WP2875,0.25100064701555647,4.065263157894737,5.6194122960417685,['SP1'],0.8014044687183777,0,0,1
39,Osteoclast Signaling WP12,0.25100064701555647,4.065263157894737,5.6194122960417685,['CTSK'],0.8014044687183777,0,0,1
40,Gastric Cancer Network 2 WP2363,0.25100064701555647,4.065263157894737,5.6194122960417685,['COL9A3'],0.8014044687183777,0,0,1
41,mRNA Processing WP411,0.25118647526993926,1.7971315734774476,2.4828445329354794,"['LSM7', 'SNRPG', 'SRSF9']",0.8014044687183777,0,0,3
42,DNA Repair Pathways Full Network WP4946,0.25118647526993926,1.7971315734774476,2.4828445329354794,"['POLD4', 'CENPX', 'POLE3']",0.8014044687183777,0,0,3
43,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2653979622897885,1.2933406714364337,1.7156485207717929,"['EGR1', 'RPL18A', 'SSR4', 'CYCS', 'RPLP2', 'ELOC', 'TXN', 'RPL26', 'RPL10A', 'TMSB10']",0.8270541150425968,0,0,10
44,Statin inhibition of cholesterol production WP430,0.2862447258018126,3.3871345029239768,4.236994152922928,['LPL'],0.8482137586605408,0,0,1
45,Nucleotide metabolism WP404,0.2862447258018126,3.3871345029239768,4.236994152922928,['NME2'],0.8482137586605408,0,0,1
46,Kallmann's Syndrome WP5074,0.3198359230086664,2.9027568922305766,3.3089894617754783,['ANOS1'],0.8482137586605408,0,0,1
47,Ovarian infertility WP34,0.3198359230086664,2.9027568922305766,3.3089894617754783,['EGR1'],0.8482137586605408,0,0,1
48,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3299819149958077,1.7682180036742192,1.9604541190625313,"['IFI27L2', 'SP1']",0.8482137586605408,0,0,2
49,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.3474175808530849,1.6942488262910798,1.7912069923262357,"['SP1', 'LPL']",0.8482137586605408,0,0,2
50,Genotoxicity pathway WP4286,0.3474175808530849,1.6942488262910798,1.7912069923262357,"['PLK3', 'RPS27']",0.8482137586605408,0,0,2
51,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.3518514961320771,2.539473684210526,2.6525972780202376,['EGR1'],0.8482137586605408,0,0,1
52,Apoptosis Modulation by HSP70 WP384,0.3518514961320771,2.539473684210526,2.6525972780202376,['CYCS'],0.8482137586605408,0,0,1
53,TP53 network WP1742,0.3518514961320771,2.539473684210526,2.6525972780202376,['SUMO1'],0.8482137586605408,0,0,1
54,7q11.23 copy number variation syndrome WP4932,0.3683208742572788,1.4187690032048648,1.41706758678027,"['ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.8482137586605408,0,0,3
55,Integrated breast cancer pathway WP1984,0.3683208742572788,1.4187690032048648,1.41706758678027,"['PLK3', 'SP1', 'FAU']",0.8482137586605408,0,0,3
56,Intraflagellar transport proteins binding to dynein WP4532,0.38236510368798937,2.2569200779727097,2.1697563756526352,['IFT22'],0.8482137586605408,0,0,1
57,Methionine De Novo and Salvage Pathway WP3580,0.38236510368798937,2.2569200779727097,2.1697563756526352,['TXN'],0.8482137586605408,0,0,1
58,Nanomaterial induced apoptosis WP2507,0.38236510368798937,2.2569200779727097,2.1697563756526352,['CYCS'],0.8482137586605408,0,0,1
59,22q11.2 copy number variation syndrome WP4657,0.39871465559711133,1.5052164840897235,1.3840605056796373,"['RANBP1', 'MRPL40']",0.8482137586605408,0,0,2
60,Type II interferon signaling (IFNG) WP619,0.4114469724845907,2.030877192982456,1.8035715294437635,['HLA-B'],0.8482137586605408,0,0,1
61,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4114469724845907,2.030877192982456,1.8035715294437635,['LPL'],0.8482137586605408,0,0,1
62,Fatty acid beta-oxidation WP143,0.4114469724845907,2.030877192982456,1.8035715294437635,['LPL'],0.8482137586605408,0,0,1
63,Oxidative Stress WP408,0.4114469724845907,2.030877192982456,1.8035715294437635,['SP1'],0.8482137586605408,0,0,1
64,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4114469724845907,2.030877192982456,1.8035715294437635,['H2AFZ'],0.8482137586605408,0,0,1
65,Pre-implantation embryo WP3527,0.4114469724845907,2.030877192982456,1.8035715294437635,['EGR1'],0.8482137586605408,0,0,1
66,Canonical and non-canonical Notch signaling WP3845,0.4391640567267738,1.845933014354067,1.5189854756321495,['MFAP1'],0.8783281134535476,0,0,1
67,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4391640567267738,1.845933014354067,1.5189854756321495,['NDUFA13'],0.8783281134535476,0,0,1
68,IL-18 signaling pathway WP4754,0.4549023143993519,1.1413890999240273,0.89904089336468,"['ARL4D', 'NRN1', 'SP1', 'COX17', 'CYCS']",0.8912535068033617,0,0,5
69,IL17 signaling pathway WP2112,0.4655801901211591,1.691812865497076,1.2933417554519253,['SP1'],0.8912535068033617,0,0,1
70,Parkinson's disease pathway WP2371,0.4655801901211591,1.691812865497076,1.2933417554519253,['CYCS'],0.8912535068033617,0,0,1
71,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.4907562308659582,1.5614035087719298,1.1114191173074488,['SP1'],0.9008402046032657,0,0,1
72,Monoamine GPCRs WP58,0.4907562308659582,1.5614035087719298,1.1114191173074488,['HRH1'],0.9008402046032657,0,0,1
73,Oxidative Damage WP3941,0.4907562308659582,1.5614035087719298,1.1114191173074488,['CYCS'],0.9008402046032657,0,0,1
74,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5147501996364887,1.449624060150376,0.9626569888927105,['CYCS'],0.9031448281957504,0,0,1
75,Endothelin Pathways WP2197,0.5147501996364887,1.449624060150376,0.9626569888927105,['RIIAD1'],0.9031448281957504,0,0,1
76,Estrogen signaling pathway WP712,0.5147501996364887,1.449624060150376,0.9626569888927105,['SP1'],0.9031448281957504,0,0,1
77,Allograft Rejection WP2328,0.5376174117350713,1.352748538011696,0.8395267031965876,['HLA-B'],0.9031448281957504,0,0,1
78,Vitamin A and carotenoid metabolism WP716,0.5376174117350713,1.352748538011696,0.8395267031965876,['LPL'],0.9031448281957504,0,0,1
79,EGF/EGFR signaling pathway WP437,0.552360917322328,1.049104423053491,0.622699718235122,"['NDUFA13', 'SP1', 'NEDD8']",0.9031448281957504,0,0,3
80,CAMKK2  Pathway WP4874,0.5594106025391588,1.2679824561403508,0.7365349283070773,['FIS1'],0.9031448281957504,0,0,1
81,Development of ureteric collection system WP5053,0.5594106025391588,1.2679824561403508,0.7365349283070773,['ANOS1'],0.9031448281957504,0,0,1
82,DNA Replication WP466,0.5594106025391588,1.2679824561403508,0.7365349283070773,['POLD4'],0.9031448281957504,0,0,1
83,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5594106025391588,1.2679824561403508,0.7365349283070773,['CYCS'],0.9031448281957504,0,0,1
84,Senescence and Autophagy in Cancer WP615,0.567527356723235,1.0674573758339512,0.6046786568988631,"['GABARAPL1', 'ING1']",0.9040014697105971,0,0,2
85,Aryl Hydrocarbon Receptor Netpath WP2586,0.5801800477247115,1.193188854489164,0.6495920537836299,['LPL'],0.9040014697105971,0,0,1
86,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5801800477247115,1.193188854489164,0.6495920537836299,['CTSK'],0.9040014697105971,0,0,1
87,TGF-beta Signaling Pathway WP366,0.6072770807163563,0.988835451734799,0.4932015733930767,"['SUMO1', 'SP1']",0.9203743107108817,0,0,2
88,Adipogenesis WP236,0.6198977234113517,0.9651240778001341,0.4615230837032602,"['SP1', 'LPL']",0.9203743107108817,0,0,2
89,NRF2 pathway WP2884,0.6322046474682055,0.9425155584670816,0.432183089819669,"['EGR1', 'TXN']",0.9203743107108817,0,0,2
90,PPAR signaling pathway WP3942,0.6368141312060805,1.0136842105263157,0.4574528294165309,['LPL'],0.9203743107108817,0,0,1
91,Gastrin signaling pathway WP4659,0.6441993543513671,0.9209346991037132,0.4049783119557304,"['EGR1', 'SP1']",0.9203743107108817,0,0,2
92,IL-4 signaling pathway WP395,0.6539460445406571,0.9652464494569758,0.4099695411078308,['HRH1'],0.9203743107108817,0,0,1
93,MET in type 1 papillary renal cell carcinoma WP4205,0.6539460445406571,0.9652464494569758,0.4099695411078308,['RPL11'],0.9203743107108817,0,0,1
94,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6539460445406571,0.9652464494569758,0.4099695411078308,['PTPRT'],0.9203743107108817,0,0,1
95,DNA IR-damage and cellular response via ATR WP4016,0.6702725139181327,0.9212121212121213,0.368550173571859,['SP1'],0.9203743107108817,0,0,1
96,Proximal tubule transport WP4917,0.6702725139181327,0.9212121212121213,0.368550173571859,['SLC7A9'],0.9203743107108817,0,0,1
97,RANKL/RANK signaling pathway WP2018,0.6702725139181327,0.9212121212121213,0.368550173571859,['CTSK'],0.9203743107108817,0,0,1
98,DNA damage response WP707,0.6858312799261321,0.8810068649885584,0.3322485062181051,['CYCS'],0.9203743107108817,0,0,1
99,Phosphodiesterases in neuronal function WP4222,0.6858312799261321,0.8810068649885584,0.3322485062181051,['PDE1C'],0.9203743107108817,0,0,1
100,miRNA regulation of DNA damage response WP1530,0.7006583207656772,0.8441520467836258,0.30029436729309145,['CYCS'],0.9203743107108817,0,0,1
101,MECP2 and Associated Rett Syndrome WP3584,0.7147879341767569,0.8102456140350878,0.2720556641002605,['SP1'],0.9203743107108817,0,0,1
102,Oncostatin M Signaling Pathway WP2374,0.7147879341767569,0.8102456140350878,0.2720556641002605,['EGR1'],0.9203743107108817,0,0,1
103,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7196489914983362,0.7935653134493234,0.2610763996697677,"['EGR1', 'SP1']",0.9203743107108817,0,0,2
104,Acute viral myocarditis WP4298,0.7282528156145553,0.7789473684210526,0.2470096763029121,['CYCS'],0.9203743107108817,0,0,1
105,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7282528156145553,0.7789473684210526,0.2470096763029121,['EGR1'],0.9203743107108817,0,0,1
106,Genes related to primary cilium development (based on CRISPR) WP4536,0.7282528156145553,0.7789473684210526,0.2470096763029121,['TEDC2'],0.9203743107108817,0,0,1
107,Leptin signaling pathway WP2034,0.741084132935849,0.7499675113710201,0.22472110537584022,['SP1'],0.9203743107108817,0,0,1
108,Translation Factors WP107,0.7533115975971145,0.7230576441102757,0.20482511475166024,['EEF1B2'],0.9203743107108817,0,0,1
109,Exercise-induced Circadian Regulation WP410,0.7533115975971145,0.7230576441102757,0.20482511475166024,['SUMO1'],0.9203743107108817,0,0,1
110,Apoptosis WP254,0.7649635323296085,0.6980036297640654,0.18701409979378464,['CYCS'],0.9203743107108817,0,0,1
111,Non-small cell lung cancer WP4255,0.7649635323296085,0.6980036297640654,0.18701409979378464,['CYCS'],0.9203743107108817,0,0,1
112,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7760669359337374,0.6746198830409357,0.17102727486591557,['PSMD7'],0.9203743107108817,0,0,1
113,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7866475447670072,0.6527447651386531,0.15664241027882045,['CYCS'],0.9203743107108817,0,0,1
114,Retinoblastoma gene in cancer WP2446,0.7967298919012259,0.6322368421052632,0.14366922412635763,['H2AFZ'],0.9203743107108817,0,0,1
115,Corticotropin-releasing hormone signaling pathway WP2355,0.8063373629062196,0.6129718234981393,0.13194406048683113,['SP1'],0.9203743107108817,0,0,1
116,Circadian rhythm related genes WP3594,0.8107947842447525,0.6515220354384371,0.13665042539443545,"['EGR1', 'RPS27A']",0.9203743107108817,0,0,2
117,Nuclear Receptors Meta-Pathway WP2882,0.8147703029698675,0.679993647516576,0.13929604747169513,"['EGR1', 'SP1', 'TXN']",0.9203743107108817,0,0,3
118,G Protein Signaling Pathways WP35,0.8154922495760304,0.5948400412796697,0.12132557399248196,['PDE1C'],0.9203743107108817,0,0,1
119,Myometrial relaxation and contraction pathways WP289,0.8242152063121224,0.6309419014084507,0.12197596637294553,"['SP1', 'GSTO1']",0.9203743107108817,0,0,2
120,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8242158006366105,0.5777443609022557,0.1116912091751892,['LPL'],0.9203743107108817,0,0,1
121,TNF-alpha signaling pathway WP231,0.8325282706397087,0.561598440545809,0.10293431055650795,['TXN'],0.9219734567414957,0,0,1
122,Apoptosis Modulation and Signaling WP1772,0.8404489661733112,0.5463252726410621,0.09496173790953935,['CYCS'],0.9231160776001944,0,0,1
123,Small cell lung cancer WP4658,0.8551877839849683,0.5181286549707602,0.08105304359016294,['CYCS'],0.9315595359931389,0,0,1
124,Spinal Cord Injury WP2431,0.862040167635442,0.5050877192982456,0.07498199489471906,['EGR1'],0.9315595359931389,0,0,1
125,Mesodermal commitment pathway WP2857,0.8807183302264678,0.46960424316605465,0.059647919453985836,['RPL38'],0.9426435798710034,0,0,1
126,Ebola Virus Pathway on Host WP4217,0.8863663512219884,0.45885167464114834,0.05534894878290267,['HLA-B'],0.9426435798710034,0,0,1
127,"GPCRs, Class A Rhodopsin-like WP455",0.9108503087099328,0.41167203723594703,0.03844058067496317,['HRH1'],0.9522687968376516,0,0,1
128,Metapathway biotransformation Phase I and II WP702,0.9150757424276738,0.4033684210526316,0.03579831751794788,['GSTO1'],0.9522687968376516,0,0,1
129,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9229371747589927,0.387719298245614,0.031092805272341328,['EGR1'],0.9522687968376516,0,0,1
130,Breast cancer pathway WP4262,0.9265915285015708,0.38033763654419067,0.028997872706349473,['SP1'],0.9522687968376516,0,0,1
131,Hepatitis B infection WP4666,0.9333902149068372,0.36637958532695375,0.025255251489880937,['CYCS'],0.9522687968376516,0,0,1
132,Regulation of Actin Cytoskeleton WP51,0.9395612215311521,0.3534010464758387,0.02203183345948012,['BRK1'],0.9522687968376516,0,0,1
133,Insulin Signaling WP481,0.9451623132791617,0.34130240856378236,0.019248980119897858,['EGR1'],0.9522687968376516,0,0,1
134,PI3K-Akt signaling pathway WP4172,0.9939037621574507,0.19210526315789472,0.0011747036606718799,['COL9A3'],0.9939037621574507,0,0,1
